An official website of the United States government
The 2023 manual is to be used for cases diagnosed January 1, 2023 and forward.
Data collection rules for hematopoietic and lymphoid neoplasms for 2010+.
The 2024 Update includes changes that apply to cases diagnosed January 1, 2024 and after.
Technical guidance regarding the implementation of COVID-19 data abstraction.
Use of terms, alternate names, abstractor notes, primary site and histology.
One-step lookup for coding oncology drug and regimen treatment categories.
Used to collect and store data abstracted from medical records.
Supports all core cancer registry functions.
Cancer Pathology Coding Histology And Registration Terminology (Cancer PathCHART) is a first-of-its-kind initiative in North America and around the world to update standards for tumor site, histology, and behavior code combinations and associated terminology.
Intended for use by cancer registrars to help assign Extent of Disease (EOD) 2018.
The most basic way of categorizing how far a cancer has spread from its point of origin.
Resources including the EOD General Instructions and the EOD Consolidation Manual.
Staging and site-specific data item (SSDI) Information for Pediatric and Adolescent/Young Adult (AYA) populations.
Frequently asked questions and resources on becoming a CTR.
Web-based training modules for cancer registration and surveillance.
Online training platform for cancer registry professionals.
Sign up to receive announcements pertinent to NCI SEER, other standard setters, and cancer registries.
